Developing a strategy for the prevention of hip fractures in the elderly due to osteoporosis: the application of economics to the findings from a clinical trial.
The occurrence of a fracture is the most obvious manifestation of osteoporosis. Preventive measures can reduce the risk of such events. The cost of preventing fractures depends on the cost and effectiveness of the intervention and the cost associated with treating the fractures. This paper aims to develop a framework for commissioners to evaluate new technologies by integrating the evidence on effectiveness with the costs likely to be incurred in providing interventions and the probable benefits generated. The explicit aim is to show how the effectiveness of an intervention designed to prevent hip fractures in the elderly, combined with an analysis of its potential economic impact, can provide an indication of how quality improvements in health-care provision and cost savings may be generated.
Phillips
C J
CJ
School of Health Science, University of Wales, Swansea, UK.
Moore
R A
RA
D000368:Aged; D002118:Calcium / Q000008:administration & dosage; D002762:Cholecalciferol / Q000008:administration & dosage; D003362:Cost-Benefit Analysis; D005260:Female; D005598:Fractures, Spontaneous / Q000517:prevention & control; D017048:Health Care Costs; D015276:Health Care Rationing; D006620:Hip Fractures / Q000517:prevention & control*; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000150:complications*
D002762:Cholecalciferol; D002118:Calcium